148 related articles for article (PubMed ID: 8421957)
1. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
[TBL] [Abstract][Full Text] [Related]
2. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
Park CK; McCulloch J; Kang JK; Choi CR
Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
[TBL] [Abstract][Full Text] [Related]
4. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
5. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
J Cereb Blood Flow Metab; 1988 Oct; 8(5):757-62. PubMed ID: 2901425
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation.
Valtysson J; Hillered L; Andiné P; Hagberg H; Persson L
Acta Neurochir (Wien); 1994; 129(1-2):58-63. PubMed ID: 7998497
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
8. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
9. Production of leukotrienes in a model of focal cerebral ischaemia in the rat.
Ciceri P; Rabuffetti M; Monopoli A; Nicosia S
Br J Pharmacol; 2001 Aug; 133(8):1323-9. PubMed ID: 11498518
[TBL] [Abstract][Full Text] [Related]
10. The sequential change of local cerebral blood flow and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effect of MK-801 on local cerebral glucose metabolism.
Liu Y; Mituska S; Hashizume K; Hosaka T; Nukui H
Acta Neurochir (Wien); 1997; 139(8):770-9. PubMed ID: 9309294
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.
Ozyurt E; Graham DI; Woodruff GN; McCulloch J
J Cereb Blood Flow Metab; 1988 Feb; 8(1):138-43. PubMed ID: 2892846
[TBL] [Abstract][Full Text] [Related]
12. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia.
Gill R; Brazell C; Woodruff GN; Kemp JA
Br J Pharmacol; 1991 Aug; 103(4):2030-6. PubMed ID: 1912992
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.
Miyabe M; Kirsch JR; Nishikawa T; Koehler RC; Traystman RJ
Crit Care Med; 1997 Jun; 25(6):1037-43. PubMed ID: 9201058
[TBL] [Abstract][Full Text] [Related]
15. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
Yang G; Chan PH; Chen SF; Babuna OA; Simon RP; Weinstein PR
Neurosurgery; 1994 Feb; 34(2):339-45; discussion 345. PubMed ID: 8177396
[TBL] [Abstract][Full Text] [Related]
16. Ischaemic brain damage--prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors.
McCulloch J
Arzneimittelforschung; 1991 Mar; 41(3A):319-24. PubMed ID: 1830483
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery.
Sharkey J; Butcher SP
J Neurosci Methods; 1995 Aug; 60(1-2):125-31. PubMed ID: 8544471
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia.
Yam PS; Dunn LT; Graham DI; Dewar D; McCulloch J
J Cereb Blood Flow Metab; 2000 May; 20(5):772-9. PubMed ID: 10826527
[TBL] [Abstract][Full Text] [Related]
20. Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes.
Dezsi L; Greenberg JH; Hamar J; Sladky J; Karp A; Reivich M
J Cereb Blood Flow Metab; 1992 May; 12(3):390-9. PubMed ID: 1314841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
